S&P 500   3,821.35 (-0.54%)
DOW   31,802.44 (+0.97%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
S&P 500   3,821.35 (-0.54%)
DOW   31,802.44 (+0.97%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
S&P 500   3,821.35 (-0.54%)
DOW   31,802.44 (+0.97%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
S&P 500   3,821.35 (-0.54%)
DOW   31,802.44 (+0.97%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
Log in
NASDAQ:OBCI

Ocean Bio-Chem Stock Forecast, Price & News

$10.82
+0.01 (+0.09 %)
(As of 03/8/2021 04:30 PM ET)
Add
Compare
Today's Range
$10.66
Now: $10.82
$10.99
50-Day Range
$9.88
MA: $11.86
$12.92
52-Week Range
$3.10
Now: $10.82
$22.55
Volume33,521 shs
Average Volume49,394 shs
Market Capitalization$102.38 million
P/E Ratio10.93
Dividend Yield0.74%
Beta0.39
Ocean Bio-Chem, Inc. manufactures, markets, and distributes appearance, performance, and maintenance products for the marine, automotive, power sports, recreational vehicle, home care, and outdoor power equipment markets in the United States and Canada. The company offers marine products, including polishes, cleaners, protectants, waxes, enzyme fuel treatments, private label products, motor and teak oils, boat washes, vinyl and teak cleaners, bilge and hull cleaners, silicone and polyurethane sealants, polysulfide sealants, gasket materials, lubricants, antifouling additives, and anti-freeze coolants; and brushes, brush handles, tie-downs, and other related accessories. It also manufactures automotive products, such as fuel treatments for gas and diesel engines, motor oils, greases, and related items; anti-freeze and windshield washes; and automotive polishes, cleaners, and other items. In addition, the company offers fuel treatment and other specialty products to the recreational vehicle market; solutions to various problems associated with E-10 fuel; and other specialty recreational vehicle/power sports products, including cleaners, polishes, detergents, fabric cleaners and protectors, silicone sealants, waterproofers, gasket materials, degreasers, vinyl cleaners and protectors, toilet treatment fluids, and anti-freeze/coolants. Further, it provides solutions to rectify operating engine problems in commercial lawn, and other home and garden power equipment; deodorizers, disinfectants, and sanitizers, as well as mildew odor control bags and boat odor sanitizers; blends and packages chemical formulations; and manufactures PVC and HDPE blow molded bottles. The company sells its products under the Star Tron, Performacide, and Star brite brands through retailers and online retailers, as well as to distributors. Ocean Bio-Chem, Inc. was founded in 1973 and is headquartered in Fort Lauderdale, Florida.

Headlines

Understanding Ocean Bio-Chem's Ex-Dividend Date
December 1, 2020 |  finance.yahoo.com
Ocean Bio-Chem authorizes $3M share repurchase program
November 23, 2020 |  seekingalpha.com
Ocean Bio-Chem +12%, shatters Q3 sales record
October 19, 2020 |  seekingalpha.com
OCEAN BIO-CHEM INC. Registered (OBC.SG)
October 9, 2020 |  au.finance.yahoo.com
Ocean Bio-Chem Not Too Compelling Even After Record Sales
September 8, 2020 |  seekingalpha.com
Ocean Bio-Chem goes ex-dividend on Tuesday
September 4, 2020 |  seekingalpha.com
Insider Sells Ocean Bio-Chem's Shares
August 26, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Polishes & sanitation goods
Sub-IndustryN/A
Current SymbolNASDAQ:OBCI
CUSIPN/A
Phone954-587-6280
Employees149
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$42.26 million
Cash Flow$0.45 per share
Book Value$3.25 per share

Profitability

Net Income$3.50 million

Miscellaneous

Market Cap$102.38 million
Next Earnings Date3/29/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

0.88 out of 5 stars

Consumer Staples Sector

178th out of 301 stocks

Polishes & Sanitation Goods Industry

2nd out of 3 stocks

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 1.3 5 -4 -3 -2 -1 -
$10.82
+0.01 (+0.09 %)
(As of 03/8/2021 04:30 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OBCI News and Ratings via Email

Sign-up to receive the latest news and ratings for OBCI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Ocean Bio-Chem (NASDAQ:OBCI) Frequently Asked Questions

What stocks does MarketBeat like better than Ocean Bio-Chem?

Wall Street analysts have given Ocean Bio-Chem a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Ocean Bio-Chem wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Ocean Bio-Chem?

Ocean Bio-Chem saw a drop in short interest in the month of February. As of February 12th, there was short interest totaling 122,200 shares, a drop of 24.3% from the January 28th total of 161,500 shares. Based on an average trading volume of 43,400 shares, the days-to-cover ratio is currently 2.8 days. Currently, 3.4% of the company's stock are sold short.
View Ocean Bio-Chem's Short Interest
.

When is Ocean Bio-Chem's next earnings date?

Ocean Bio-Chem is scheduled to release its next quarterly earnings announcement on Monday, March 29th 2021.
View our earnings forecast for Ocean Bio-Chem
.

How were Ocean Bio-Chem's earnings last quarter?

Ocean Bio-Chem, Inc. (NASDAQ:OBCI) posted its earnings results on Monday, August, 10th. The company reported $0.36 earnings per share for the quarter. The business had revenue of $15.70 million for the quarter. Ocean Bio-Chem had a trailing twelve-month return on equity of 27.70% and a net margin of 17.91%.
View Ocean Bio-Chem's earnings history
.

How has Ocean Bio-Chem's stock price been impacted by Coronavirus?

Ocean Bio-Chem's stock was trading at $3.65 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, OBCI shares have increased by 197.0% and is now trading at $10.84.
View which stocks have been most impacted by COVID-19
.

How often does Ocean Bio-Chem pay dividends? What is the dividend yield for Ocean Bio-Chem?

Ocean Bio-Chem declared a quarterly dividend on Tuesday, March 2nd. Investors of record on Thursday, March 11th will be given a dividend of $0.03 per share on Thursday, March 25th. This represents a $0.12 annualized dividend and a dividend yield of 1.11%. The ex-dividend date is Wednesday, March 10th. This is an increase from Ocean Bio-Chem's previous quarterly dividend of $0.02.
View Ocean Bio-Chem's dividend history
.

Is Ocean Bio-Chem a good dividend stock?

Ocean Bio-Chem pays an annual dividend of $0.08 per share and currently has a dividend yield of 0.74%.
View Ocean Bio-Chem's dividend history.

Who are Ocean Bio-Chem's key executives?

Ocean Bio-Chem's management team includes the following people:
  • Mr. Peter G. Dornau, Co-Founder, Chairman, CEO & Pres (Age 81, Pay $239.53k)
  • Mr. Jeffrey S. Barocas, CFO, VP of Fin. & Director (Age 73, Pay $235.04k)
  • Mr. William W. Dudman, COO, VP, Sec. & Director (Age 56, Pay $232.62k)
  • Mr. Gregor M. Dornau, Exec. VP of Sales & Marketing & Director (Age 52, Pay $247.32k)
  • Anca Vague, Controller of Financial Reporting

What is Peter G. Dornau's approval rating as Ocean Bio-Chem's CEO?

1 employees have rated Ocean Bio-Chem CEO Peter G. Dornau on Glassdoor.com. Peter G. Dornau has an approval rating of 100% among Ocean Bio-Chem's employees. This puts Peter G. Dornau in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Ocean Bio-Chem's key competitors?

What other stocks do shareholders of Ocean Bio-Chem own?

What is Ocean Bio-Chem's stock symbol?

Ocean Bio-Chem trades on the NASDAQ under the ticker symbol "OBCI."

Who are Ocean Bio-Chem's major shareholders?

Ocean Bio-Chem's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (2.79%), Worth Venture Partners LLC (1.65%), Dimensional Fund Advisors LP (0.83%), Dimensional Fund Advisors LP (0.83%), Ancora Advisors LLC (0.71%) and Bank of New York Mellon Corp (0.38%). Company insiders that own Ocean Bio-Chem stock include Gregor M Dornau, Jeffrey Barocas and William Dudman.
View institutional ownership trends for Ocean Bio-Chem
.

Which major investors are selling Ocean Bio-Chem stock?

OBCI stock was sold by a variety of institutional investors in the last quarter, including Worth Venture Partners LLC, Essex Investment Management Co. LLC, Renaissance Technologies LLC, and GWM Advisors LLC. Company insiders that have sold Ocean Bio-Chem company stock in the last year include Gregor M Dornau, Jeffrey Barocas, and William Dudman.
View insider buying and selling activity for Ocean Bio-Chem
or view top insider-selling stocks.

Which major investors are buying Ocean Bio-Chem stock?

OBCI stock was bought by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Ancora Advisors LLC, Wells Fargo & Company MN, Dimensional Fund Advisors LP, Dimensional Fund Advisors LP, and BlackRock Inc..
View insider buying and selling activity for Ocean Bio-Chem
or or view top insider-buying stocks.

How do I buy shares of Ocean Bio-Chem?

Shares of OBCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ocean Bio-Chem's stock price today?

One share of OBCI stock can currently be purchased for approximately $10.84.

How much money does Ocean Bio-Chem make?

Ocean Bio-Chem has a market capitalization of $102.57 million and generates $42.26 million in revenue each year.

How many employees does Ocean Bio-Chem have?

Ocean Bio-Chem employs 149 workers across the globe.

What is Ocean Bio-Chem's official website?

The official website for Ocean Bio-Chem is www.oceanbiochem.com.

Where are Ocean Bio-Chem's headquarters?

Ocean Bio-Chem is headquartered at 4041 SW 47 AVENUE, FORT LAUDERDALE FL, 33314.

How can I contact Ocean Bio-Chem?

Ocean Bio-Chem's mailing address is 4041 SW 47 AVENUE, FORT LAUDERDALE FL, 33314. The company can be reached via phone at 954-587-6280.


This page was last updated on 3/8/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.